REVLIMID Adverse Event: Memory impairment
REVLIMID Adverse Event: Memory impairment is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: REVLIMID; Product category: Drug; Primary reaction: Memory impairment.
| Primary drug | REVLIMID |
|---|---|
| Product category | Drug |
| Primary reaction | Memory impairment |
| All reactions | Memory impairment; Chronic lymphocytic leukaemia |
| Seriousness | Not serious |
| Patient outcome | Unknown |
| Patient sex | Male |
| All drugs reported | REVLIMID; REVLIMID; LEUKERAN; LEUKERAN |
| Reporter country | US |
| Reporter type | 1 |
| Report date | 20140313 |
| Report ID | 10006105 |
$299/mo
Try FDATracker →